According to IQVIA, sevelamer hydrochloride tablets had estimated annual sales of $80 million in the US.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets.
The drug majors consolidated net profit jumped 18.7% to Rs 464.37 crore on 0.8% fall in net sales to Rs 3,759.27 crore in Q4 March 2021 over Q4 March 2020.
Shares of Lupin were trading 1.26% lower at Rs 1,162 on BSE.
Powered by Capital Market - Live News